Robert Boyle (1671) was the first to produce hydrogen when he dissolved iron in diluted hydrochloric acid. Th is observation occurred long before it was actually discovered as a distinct gas in 1766 by Henry Cavendish, who originally called it ' inflammable air ' ; it was later named hydrogen (Greek hydro , ' water, ' and genes , ' forming ' ) by Lavoisier, the father of modern chemistry. On earth, free hydrogen is comparatively rare. Th e majority of hydrogen found on earth is in water and organic compounds. It is highly reactive in the presence of specifi c catalysts and / or heat. One of the more spectacular examples of its reactivity was shown in 1937 when the zeppelin Hindenburg , using hydrogen for lift , ignited and was destroyed in less than a minute in the ensuing confl agration. Th erefore, the use of hydrogen as a therapeutic agent is not intuitively obvious. However, recent data have shown that hydrogen can behave as an antioxidant in biological systems because of its ability to reduce ROS. 7 ROS or free radicals, such as the superoxide anion (O 2 − ), are generated through the leak of electrons to molecular oxygen in the mitochondria during the production of adenosine triphosphate by oxidative phosphorylation ( Figure 1 ). In the normal state, mitochondria generate 2 -3 nmol of superoxide anion per minute per milligram of protein, 8 resulting in the generation of the superoxide radical, hydrogen peroxide, and the highly toxic hydroxyl radical. Th ese ROS can be safely reduced to water by superoxide dismutase, catalase, and glutathione peroxidase ( Figure 1 ). During ischemia -reperfusion injury, which inevitably occurs during organ transplantation, the balance between the generation of ROS and the mechanisms to detoxify them can be upset, resulting in the accumulation of ROS in the tissues, where they quickly react with lipids, proteins, and nucleic acids, causing disordered cellular functions.
The paper by Cardinal and colleagues 5 is based on the premise that oxidative stress, resulting from ischemia -reperfusion, is a common pathway of injury in the setting of transplantation and is therefore a significant contributor to the deve lopment of CAN. These findings are an extension of the elegant work of Ohsawa and colleagues, who were the first to demonstrate that inhalation of hydrogen gas was an effective antioxidant strategy in cultured neuronal cells and in a model of ischemia -reperfusion in the brain in vivo . 7 These authors also showed that hydrogen gas was capable of rapidly diffusing through membrane compartments, gaining ready access to the cytosol, mitochondria, and nucleus and reducing hydroxyl radicals (·OH; the strongest of oxidant species in living cells) but did not appear to compromise essential homeostatic mechanisms dependent on ROS. 7 Cardinal and colleagues 5 show that the administration of water containing dissolved hydrogen results in (1) a sustained increase in the levels of hydrogen in the kidney and serum, without any accumulation over time; (2) improved kidney allograft function over a 60-day follow-up period; (3) a decrease in several markers of infl ammation, including graft -infi ltrating cells, proinfl ammatory cytokines, and mitogen-activated protein kinase activation; and (4) decreased levels of lipid peroxides and peroxynitrite in the tissues.
A variety of other gases, such as NO, CO, and H 2 S, are considered poisonous in large amounts but, in smaller concentrations, have antioxidant properties or are involved in physiological functions. Given previous data, the interpretation that the benefi cial eff ects of H 2 in a kidney transplant model are a result of antioxidant properties of the element is reasonable and likely. However, this may not be the sole explanation, and other as-yet undefi ned mechanisms may be involved. Th e presence of basal levels of H 2 indicates one or more endogenous sources, suggesting that it plays a physiological role. Precedent for this possibility can be easily found in other gas-generating systems. CO, which is endogenously generated during the degradation of heme by the heme oxygenase enzyme system, 9 was previously thought of exclusively as a toxic gas. It is now understood that CO, which also has benefi cial eff ects in infl ammation and oxidative stress, plays a physiological role and participates in several signaling pathways known to modulate inflammation. 2 In fact, several clinical trials using inhaled CO are ongoing, including one in kidney transplant recipients. NO has attracted the most attention because of its involvement in cardiovascular biology, blood pressure regulation, and kidney and vascular function. NO is generated from arginine by nitric oxide synthases and has a number of molecular targets, including guanylate cyclase (which CO also targets) and phosphodiesterases. 1 Therefore, given the increasing number of systems in which H 2 is being shown to mediate beneficial eff ects, and likely, in the future, deleterious ones as well, it is probable that involvement of H 2 in signaling pathways or other physiological functions will be found. Th e molecular gases, H 2 , NO, and H 2 S are much simpler in structure than many of the drugs in use today. Our knowledge of them will continue to expand, providing an exciting potential for an entirely new class of drugs in the treatment of kidney diseases and end-stage organ failure. 
